Lower baseline cognitive scores did not translate into significantly worse treatment retention for the methamphetamine group in a German inpatient study. The study is useful because it separates differences on entry from outcomes during treatment.
Behle and colleagues recruited 110 patients: 55 with methamphetamine dependence and 55 dependent on other substances. They assessed participants near the beginning of a six-month inpatient program and again at its end. Measures included cognitive working speed and accuracy, craving, depressive symptoms and personality characteristics.
This was an observational longitudinal study. Patients were not randomized to methamphetamine exposure, and there was no untreated comparison group establishing the isolated effect of the program.
The methamphetamine group had fewer years of education, lower intelligence scores and poorer working speed and accuracy at baseline. Nevertheless, dropout was 36.4% in that group and 43.6% in the other-substance group, a nonsignificant difference. The overall dropout rate was 40%.
Among participants assessed after treatment, both groups showed improvements in working speed and accuracy and reductions in craving and depressive symptoms. These observations challenge an assumption that methamphetamine patients must necessarily fare worse in an established inpatient program.
Follow-up treatment-effect analyses were limited to completers. Outcomes were unavailable for those who dropped out, so the improvements cannot be attributed to the entire starting sample. Attrition may select people with different experiences or capacities.
The authors also did not adjust analyses for multiple testing, describing the work as exploratory. The other-substance group could include amphetamine users, making it an imperfect stimulant-free comparison. A nonsignificant retention difference is not a formal demonstration of equal treatment effectiveness.
The paper supports evaluating treatment prospects using actual evidence rather than baseline stereotypes. It does not establish which component produced improvement or whether results persist after discharge. Cognitive change also requires separating intervention effects from repeat-testing effects, discussed in our analysis of practice effects during abstinence.